Infectious disease surveillance in U.S. jails: Findings from a national survey

PLoS One. 2022 Aug 25;17(8):e0272374. doi: 10.1371/journal.pone.0272374. eCollection 2022.

Abstract

While infectious diseases (ID) are a well-documented public health issue in carceral settings, research on ID screening and treatment in jails is lacking. A survey was sent to 1,126 jails in the United States to identify the prevalence of health screenings at intake and characteristics of care for ID; 371 surveys were completed correctly and analyzed. Despite conflicting Centers for Disease Control (CDC) guidance, only seven percent of surveyed jails test individuals for HIV at admission. In 46% of jails, non-healthcare personnel perform ID screenings. Jails in less urban areas were more likely to report healthcare screenings performed by correctional officers. Survey findings indicate that HIV, HCV and TB testing during jail admissions and access to PrEP are severely lacking in less urban jails in particular. Recommendations are provided to improve ID surveillance and address the burden of ID in correctional facilities.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Communicable Diseases* / diagnosis
  • Communicable Diseases* / epidemiology
  • HIV Infections* / diagnosis
  • HIV Infections* / epidemiology
  • HIV Infections* / prevention & control
  • Humans
  • Jails
  • Mass Screening
  • Prisons
  • United States / epidemiology